COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu
Trial record 45 of 360 for:    ASPIRIN AND clopidogrel AND Purinergic Antagonists

CES1 Carriers in the PAPI Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03188705
Recruitment Status : Enrolling by invitation
First Posted : June 15, 2017
Last Update Posted : November 12, 2019
Information provided by (Responsible Party):
Joshua Lewis, University of Maryland, Baltimore

No Study Results Posted on for this Study
Recruitment Status : Enrolling by invitation
Estimated Primary Completion Date : September 2020
Estimated Study Completion Date : September 2020